Diversity of axin in signaling pathways and its relation to colorectal cancer (original) (raw)

• Cancer. World Health Organization. February 2006. Retrieved on 2007-05-24.
• Colorectal cancer facts and figures 2008.
• Vainio H, Miller AB. Primary secondary prevention in CRC. Acta Oncol. 2003;42:809–15.
  Article PubMed Google Scholar
• Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–6.
  Article PubMed Google Scholar
• Dhar GM, Shah GN, Naheed B, Hafiza. Epidemiological trend in the distribution of cancer in Kashmir Valley. J Epidenmiol Conmnm Health. 1993;47:290–2.
  Article CAS Google Scholar
• Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33(1):11–5.
  Article PubMed CAS Google Scholar
• O’brien MJ, Winawer SJ, Zauber AG. Flat adenomas in the National Polyp Study: is there increased risk forhigh-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol. 2004;2:905–11.
  Article PubMed Google Scholar
• Zauber AG, O’Brien MJ, Winawer SJ. On finding flat adenomas: is the search worth the gain? Gastroenterology. 2002;122:839–40.
  Article PubMed Google Scholar
• Paula MC, Harold F. The genetics of CRC. Ann Intern Med. 2002;137:603–12.
  Google Scholar
• Zeng L, Fagotto F, Zhang T, et al. The mouse fused locus encodes Axin, an inhibitor of the Wnt signalling pathway that regulates embryonic axis formation. Cell. 1997;90:181–92.
  Article PubMed CAS Google Scholar
• Cong F, Varmus H. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci USA. 2004;101:2882–7.
  Article PubMed CAS Google Scholar
• Yamamoto H, Kishida S, Uochi T, et al. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3 beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol. 1998;18:2867–75.
  PubMed CAS Google Scholar
• Mai M, Qian C, Yokomizo A, et al. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23–q24. Genomics. 1999;55:341–4.
  Article PubMed CAS Google Scholar
• Liu W, Dong X, Mai M, et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet. 2000;26:146–7.
  Article PubMed CAS Google Scholar
• Dong X, Seelan RS, Qian C, et al. Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene. Cytogenet Cell Genet. 2001;93:26–8.
  Article PubMed CAS Google Scholar
• Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science. 1998;280:596–9.
  Article PubMed CAS Google Scholar
• Hart MJ, los Santos DR, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human Axin and its association with th APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol. 1998;573–581.
• Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 1998;17:1371–84.
  Article PubMed CAS Google Scholar
• Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F. Domains of Axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol. 1999;145:741–56.
  Article PubMed CAS Google Scholar
• Hsu W, Zeng L, Costantini F. Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem. 1999;274:3439–45.
  Article PubMed CAS Google Scholar
• Julius MA, Schelbert B, Hsu W, Fitzpatrick E, Jho E, Fagotto F, Costantini F, Kitajewski J. Domains of Axin and disheveled required for interaction and function in Wnt signaling. Biochem Biophys Res Commun. 2000;276:1162–9.
  Article PubMed CAS Google Scholar
• Kishida S, Yamamoto H, Hino SI, Ikeda S, Kishida M, Kikuchi A. DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate -catenin stability. Mol Cell Biol. 1999;19:4414–22.
  PubMed CAS Google Scholar
• Li L, Yuan H, Weaver CD, Mao J, Farr GH III, Sussman DJ, Jonkers J, Kimelman D, Wu D. Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J. 1999;18:4233–40.
  Article PubMed CAS Google Scholar
• Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, Jayatilake H, Fryer LG, Hutchinson L, Fry MJ, Dale TC. Interaction of Axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J. 1999;18:2823–35.
  Article PubMed CAS Google Scholar
• Schwarz-Romond T, Asbrand C, Bakkers J, Ku¨hl M, Schaeffe HJ, Huelsken RJ, Behrens J, Hammerschmidt M, Birchmeier W. The ankyrin repeat protein Diversin recruits Casein kinase Iε to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev. 2002;16:2073–84.
  Article PubMed CAS Google Scholar
• Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M. Axin facilitates Smad3activation in the transforming growth factor signaling pathway. Mol Cell Biol. 2001;21:5132–41.
  Article PubMed CAS Google Scholar
• Itoh K, Krupnik VE, Sokol SY. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol. 1998;8:591–4.
  Article PubMed CAS Google Scholar
• Sakanaka C, Weiss JB, Williams LT. Bridging of beta-catenin and glycogen synthase kinase-3beta by Axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci USA. 1998;95:3020–3.
  Article PubMed CAS Google Scholar
• Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004;74:1043–50.
  Article PubMed CAS Google Scholar
• Yu HM, Jerchow IB, Sheu TJ, Liu B, Costantin Fi, Puzas JE, Birchmeier W, Hsu W. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development. 2005;132:1995–2005.
  Article PubMed CAS Google Scholar
• Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 2000;24:245–50.
  Article PubMed CAS Google Scholar
• Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21:4863–71.
  Article PubMed CAS Google Scholar
• Aulehla A, Wehrle C, Brand-Saberi B, Kemler R, Gossler A, Kanzler B, Herrmann BG. Wnt3a plays a major role in the segmentation clock controlling somitogenesis. Dev Cell. 2003;4:395–406.
  Article PubMed CAS Google Scholar
• Jho E, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. Wnt/-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172–83.
  Article PubMed CAS Google Scholar
• Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem. 2002;277:21657–65.
  Article PubMed CAS Google Scholar
• Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22:1184–93.
  Article PubMed CAS Google Scholar
• Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C, Garcia PD, Randazzo FM, Escobedo J, Fantl WJ, Williams LT. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA. 2001;98:14973–8.
  Article PubMed CAS Google Scholar
• Anderson CB, Neufeld KL, White RL. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci USA. 2002;99:8683–8.
  Article PubMed CAS Google Scholar
• Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 2003;1:E10.
  Article PubMed Google Scholar
• Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell. 2001;7:801–9.
  Article PubMed CAS Google Scholar
• Wehrli M, Dougan ST, Caldwell K, O’Keefe L, Schwartz S. Vaizel D: arrow encodes an LDLreceptor-related protein essential for Wingless signaling. Nature. 2000;407:527–30.
  Article PubMed CAS Google Scholar
• Tolwinski NS, Wehrli M, Rives A, Erdeniz N, DiNardo S, Wieschaus E. Wg/Wnt signal canbe transmitted through arrow/LRP5, 6 and Axin independently of Zw3/GSK-3ß activity. Dev Cell. 2003;4:407–18.
  Article PubMed CAS Google Scholar
• Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A. Axin, anegative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of ß-catenin. J Biol Chem. 1998;273:10823–6.
  Article PubMed CAS Google Scholar
• Hart MJ, de los Santos R, Albert IN, Polakis P. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK-3β. Curr Biol. 1998;8:573–81.
  Article PubMed CAS Google Scholar
• Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T. Axin, an inhibitor of the Wnt signaling pathway, interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level. Genes Cells. 1998;3:395–403.
  Article PubMed CAS Google Scholar
• Rubinfeld B, Tice DA, Polakis P. Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase IÂ. J Biol Chem. 2001;276:39037–45.
  Article PubMed CAS Google Scholar
• Shiomi K, Uchida H, Keino-Masu K, Masu M. Ccd1, a novel protein with a DIX domain, is a positive regulator in the Wnt signaling during zebrafish neural patterning. Curr Biol. 2003;13:73–7.
  Article PubMed CAS Google Scholar
• Kadoya T, Kishida S, Fukui A, Hinoi T, Michiue T, Asashima M, Kikuchi A. Inhibition of Wnt signaling pathway by a novel Axin-binding protein. J Biol Chem. 2000;275:37030–7.
  Article PubMed CAS Google Scholar
• Cliffe A, Hamada F, Bienz M. A role of Dishevelled in relocating axin to the plasma membrane during wingless signaling. Curr Biol. 2003;13:960–6.
  Article PubMed CAS Google Scholar
• Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3ß regulates its stability. J Biol Chem. 1999;274:10681–4.
  Article PubMed CAS Google Scholar
• Zhang Y, Neo SY, Wang X, Han J, Lin SC. Axin forms a complex with MEKK1 and activatesc-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem. 1999;274:35247–54.
  Article PubMed CAS Google Scholar
• Luo W, Ng WW, Jin LH, Ye Z, Han J, Lin SC. Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation. J Biol Chem. 2003;278:37451–8. Axin: a master scaffold for multiple signaling pathways neurosignals 2004;13:99–113 111.
  Article PubMed CAS Google Scholar
• Kusano S, Raab-Traub N. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol. 2002;22:6393–405.
  Article PubMed CAS Google Scholar
• Yamazaki H, Nusse R. Identification of DCAP, a Drosophila homolog of a glucose transport regulatory complex. Mech Dev. 2002;119:115–9.
  Article PubMed CAS Google Scholar
• Cowan CA, Henkemeyer M. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature. 2001;413:174–9.
  Article PubMed CAS Google Scholar
• Zhang Y, Qiu WJ, Liu DX, Neo SY, He X, Lin SC, Lin SC. Differential molecular assemblies under liethe dual function of Axin in modulating theWnt and JNK pathways. J Biol Chem. 2000;276:32152–9.
  Article Google Scholar
• Zhang Y, Neo SY, Han J, Lin SC. Dimerization choices control the ability of Axin and disheveled to activate c-Jun N-terminal kinase/stress-activated protein kinase. J Biol Chem. 2000;275:25008–14.
  Article PubMed CAS Google Scholar
• Zhang Y, Qiu WJ, Chan SC, Han J, He X, Lin SC. Casein kinase I and casein kinase II differentially regulate Axin function in Wnt and JNK pathways. J Biol Chem. 2002;277:17706–12.
  Article PubMed CAS Google Scholar
• Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, Lin SC. SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem. 2002;277:42981–6.
  Article PubMed CAS Google Scholar
• Lustig BJ, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol. 2003;129:199–221.
  PubMed CAS Google Scholar
• Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–91.
  Article PubMed CAS Google Scholar
• Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–71.
  Article PubMed CAS Google Scholar
• Chakrabarty S, Fan D, Varani J. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int J Cancer. 1990;46:493–9.
  Article PubMed CAS Google Scholar
• Derynck R, Zhang Y, Feng X-H. Smads: transcriptional activators of TGF-b responses. Cell. 1998;95:737–40.
  Article PubMed CAS Google Scholar
• Miyazono K, ten Dijke P, Heldin C-H. TGF-b signaling by Smad proteins. Adv Immunol. 2000;75:115–57.
  Article PubMed CAS Google Scholar
• Pierreux CE, Nicola′s FJ, Hill CS. Transforming growth factor b-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol. 2000;20:9041–54.
  Article PubMed CAS Google Scholar
• Xiao Z, Liu X, Lodis HF. Importin b mediates nuclear translocation of Smad 3. J Biol Chem. 2000;275:23425–8.
  Article PubMed CAS Google Scholar
• Miura S, Takeshita T, Asao H, Kimura Y, Murata K, Sasaki Y, Hanai JI, Beppu H, Tsukazaki T, Wrana JL, Miyazono K, Sugamura K. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol. 2000;20:9346–55.
  Article PubMed CAS Google Scholar
• Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFb receptor. Cell. 1998;95:779–91.
  Article PubMed CAS Google Scholar
• Dong C, Li Z, Alvarez R Jr, Feng X-H, Goldschmidt-Clermont PJ. Microtubule binding to Smads may regulate TGFb activity. Mol Cell. 2000;5:27–34.
  Article PubMed CAS Google Scholar
• Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. GSK-3b-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by b-catenin and protein phosphatase 2A complexed with Axin. Oncogene. 2000;19:537–45.
  Article PubMed CAS Google Scholar
• Massague J, Blain SW, Lo RS. TGFb signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295–309.
  Article PubMed CAS Google Scholar
• Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp Cell Res. 1989;181:442–53.
  Article PubMed CAS Google Scholar
• Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev. 1995;4:549–54.
  PubMed CAS Google Scholar
• Robson H, Anderson E, James RD, Schofield PF. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer. 1996;74:753–8.
  Article PubMed CAS Google Scholar
• Sheng H, Shao J, O’Mahony CA, Lamps L, Albo D, Isakson PC, Berger DH, DuBois RN, Beauchamp RD. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Oncogene. 1999;18:855–67.
  Article PubMed CAS Google Scholar
• Schroy P, Rifkin J, Coffey RJ, Winawer S, Friedman E. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res. 1990;50:261–5.
  PubMed CAS Google Scholar
• Claire RW, Roger JD. The JNK signal transduction pathway. Curr Opin Genet Dev. 2002;12:14–21.
  Article Google Scholar
• Hagemann C, Blank JL. The ups and downs of MEK kinase interactions. Cell Signal. 2001;13:863–75.
  Article PubMed CAS Google Scholar
• Zhang Y, Qiu WJ, Liu DX, Neo SY, He X, Lin SC. Differential molecular assemblies under liethe dual function of Axin in modulating the Wnt and JNK pathways. J Biol Chem. 2001;276:32152–9.
  Article PubMed CAS Google Scholar
• Webster MT, Rozycka M, Sara E, et al. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer. 2000;28:443–53.
  Article PubMed CAS Google Scholar
• Bellamy CO, Malcomson RD, Harrison DJ, et al. Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol. 1995;6:3–16.
  Article PubMed CAS Google Scholar
• Wu R, Zhai Y, Fearon ER, et al. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 2001;61:8247–55.
  PubMed CAS Google Scholar
• Domingo E, Espin E, Armengol M, et al. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer. 2004;39:138–42.
  Article PubMed CAS Google Scholar
• Li-Hua JIN, Qiu-Jie SHAO, Wen LUO, Zhi-Yun YE, Qing LI and Sheng-Cai. LIN1, detection of point mutations of the axin1 gene in colorectal cancers. Int. J Cancer. 2003;107:696–99.
• Marie-Therese W, Magdalena R, Elizabeth S, Elaine D, Matthew S, Neville Y. Sequence Variants of the Axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding chromosomes & cancer 2000;28:443–453.
• Soichi I, Wataru K, Chie K, Shigeki A, Mitsuhiro N, Yoshiaki Y. Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2005;131:773–82.
  Article Google Scholar